Your session is about to expire
← Back to Search
Team-Based Care for Opioid Use Disorder and Mental Health Disorders (STAR-COD Trial)
N/A
Recruiting
Led By David Smelson, PsyD
Research Sponsored by University of Massachusetts, Worcester
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Must not have
Are incompetent and unable to provide informed consent
Are not fluent in English or Spanish
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 months
Awards & highlights
No Placebo-Only Group
Summary
This trial will test whether a team approach to treating people with substance abuse and mental health disorders is more effective than treating them with medication for substance abuse alone.
Who is the study for?
This trial is for adults fluent in English or Spanish with opioid use disorder (OUD) and a co-occurring mental health disorder like depression, anxiety, trauma-related disorders, bipolar, or schizophrenia. Participants can be new to treatment or have relapsed while on medications such as buprenorphine or naltrexone. Excluded are those acutely psychotic/suicidal/homicidal, severely addicted to alcohol needing detoxification, or unable to consent.
What is being tested?
The study tests the MISSION model—a comprehensive care approach—against standard medication treatments for OUD alone. It examines if adding MISSION's therapy and support services improves patient engagement and outcomes in substance use and mental health over just using medications like buprenorphine/naltrexone.
What are the potential side effects?
While specific side effects aren't listed here, interventions may include typical risks associated with behavioral therapies and peer support activities. Medications for OUD could cause nausea, headaches, dizziness among others; however these will vary based on individual conditions.
Eligibility Criteria
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
I am unable to understand and give consent for medical procedures.
Select...
I am not fluent in English or Spanish.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 12 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 months
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Chronic pain
Engagement in medication for opioid use disorder (MOUD)
Engagement in outreach and linkage sessions
+14 moreSecondary study objectives
Mortality
Other study objectives
Economic impact of CTI & DRT
Economic impact of CTI & PS
Economic impact of MOUD alone
+2 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
5Treatment groups
Experimental Treatment
Group I: MOUD onlyExperimental Treatment1 Intervention
MOUD
Group II: Full MISSIONExperimental Treatment4 Interventions
CTI + DRT + PS + MOUD
Group III: DRT & PSExperimental Treatment3 Interventions
DRT + PS + MOUD
Group IV: CTI & PSExperimental Treatment3 Interventions
CTI + PS + MOUD
Group V: CTI & DRTExperimental Treatment3 Interventions
CTI + DRT + MOUD
Find a Location
Who is running the clinical trial?
University of Massachusetts, WorcesterLead Sponsor
362 Previous Clinical Trials
992,050 Total Patients Enrolled
Harvard Medical School (HMS and HSDM)OTHER
203 Previous Clinical Trials
1,315,459 Total Patients Enrolled
Cornell UniversityOTHER
171 Previous Clinical Trials
14,088,193 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am fluent in either English or Spanish.I have opioid use disorder and recently relapsed despite being in a treatment program.I have a stable mental health condition but my symptoms have recently worsened.I am 18 years old or older.I am unable to understand and give consent for medical procedures.I am not fluent in English or Spanish.
Research Study Groups:
This trial has the following groups:- Group 1: CTI & DRT
- Group 2: MOUD only
- Group 3: Full MISSION
- Group 4: DRT & PS
- Group 5: CTI & PS
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Share this study with friends
Copy Link
Messenger